Mevigut SR 200 mg

NIPRO JMI Pharma Ltd. · Capsule (Sustained Release)

GenericMebeverine Hydrochloride

Strength200 mg

Total Strip3

Strip Size10

Unit Price

৳ 10

/ Piece

Order Now

⚠ Disclaimer

The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.

Medicine Description

INDICATIONS

Mebeverine is indicated for the:

Symptomatic treatment of irritable bowel syndrome (IBS)
Chronic irritable colon
Spastic constipation
Mucous colitis
Colicky abdominal pain
Persistent non-specific diarrhoea

DOSAGE & ADMINISTRATION

For adults, elderly and children over 10 years:

Mebeverine Hydrochloride 135 mg tablet: 1 tablet 03 times daily.
Mebeverine Hydrochloride 200 mg capsule: 1 capsule 02 times daily.

This is most effective when taken 20 minutes before meals. After several weeks when the desired effect has been obtained, the dosage may be gradually reduced.Missed dose: If a dose of this medicine is missed, that should be taken as soon as possible. However, if it is almost time for the next dose, then skip the missed dose and the regular dosing schedule should be maintained. Dose should not be doubled at the same time to compensate the missed dose.Use in children: Mebeverine is not recommended for children under 10 years.

SIDE EFFECTS

Generally Mebeverine is well tolerated. However, few side-effects like skin rash, urticaria and angioedema may appear

PREGNANCY & LACTATION

No teratogenicity has been shown in animal experiments. However, the usual precautions concerning the administration of any drug during pregnancy should be exercised. Mebeverine does not excrete in the breast milk after administering at therapeutic dose.